BIOTEC Develops Inhaled COVID Vaccines
The National Center for Genetic Engineering and Biotechnology (BIOTEC) developed inhaled COVID-19 vaccines of adenovirus-based and influenza-based types to prevent infections, reduce side effects and combat mutations.